FindMyKOL
Clinical trialNCT04157686CompletedPhase 3Interventional

MT10109L in the Long-term, Open-label Treatment of Glabellar Lines (GL) and Lateral Canthal Lines (LCL)

SponsorMedy-ToxEnrollment957Glabellar LinesLateral Canthal Lines
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

To evaluate the long-term safety of MT10109L in the treatment of GL and/or LCL in participants with moderate to severe GL and/or LCL.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

38 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Belgium
  • Uz Brussel

    Jette, Brussels Capital, Belgium

  • Medical Skincare

    Sint-Truiden, Limburg, Belgium

Canada
  • Dr. Shannon Humphrey Inc.

    Vancouver, British Columbia, Canada

  • Pacific Derm

    Vancouver, British Columbia, Canada

  • Project Skin Md Ltd

    Vancouver, British Columbia, Canada

  • Dermetics Cosmetic Dermatology

    Burlington, Ontario, Canada

  • the Center for Dermatology

    Richmond Hill, Ontario, Canada

  • Sweat Clinics of Canada

    Toronto, Ontarion, Canada

Germany
  • Rosenpark Research

    Darmstadt, Germany

  • Privatpraxis Dr. Hilton & Partner

    Düsseldorf, Germany

  • Hautok and Hautok-Cosmetics

    München, Germany

  • Studienzentrum Theatiner46

    München, Germany

  • Medicorium Zentrum Fuer Dermatologie Und Aesthetik

    Oberursel, Germany

Russia
  • Kazan State Medical University

    Kazan', Russia

  • Center Dermatovenereology and Cosmetology

    Moscow, Russia

  • Medical Center Capital - Zdorovie Llc

    Moscow, Russia

  • State Budget Institution of Higher Education North

    Saint Petersburg, Russia

United Kingdom
  • Meyer Clinic

    Chichester, United Kingdom

  • Nhs Lanarkshire

    Glasgow, United Kingdom

  • Medizen Premier Aesthetic Clinic

    Sutton Coldfield, United Kingdom

United States
  • Clear Dermatology & Aesthetics Center

    Scottsdale, Arizona, United States

  • the Eye Research Foundation

    Newport Beach, California, United States

  • Art of Skin Md

    Solana Beach, California, United States

  • Susan H. Weinkle

    Bradenton, Florida, United States

  • Skin Research Institute

    Coral Gables, Florida, United States

  • Coleman Center for Cosmetic Dermatologic Surgery

    Metairie, Louisiana, United States

  • Etre Cosmetic Dermatology and Laser Center

    New Orleans, Louisiana, United States

  • Md Laser Skin & Vein

    Hunt Valley, Maryland, United States

  • Laser & Skin Surgery Center of New York

    New York, New York, United States

  • Skin Search of Rochester Inc.

    Rochester, New York, United States

  • M3 Wake Research Inc.

    Raleigh, North Carolina, United States

  • Wilmington Dermatology Center

    Wilmington, North Carolina, United States

  • Aventiv Research Dublin

    Dublin, Ohio, United States

  • Dermresearch Inc.

    Austin, Texas, United States

  • Westlake Dermatology & Cosmetic Surgery - Westlake

    Austin, Texas, United States

  • Bellaire Dermatology

    Bellaire, Texas, United States

  • Skindc

    Arlington, Virginia, United States

  • Virginia Clinical Research, Inc.

    Norfolk, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

MT10109L Dose 1MT10109L Dose 1 + Dose 2MT10109L Dose 2
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
23 Oct 2019
Primary completion
16 Feb 2023
Completion
16 Feb 2023
Last update posted
9 Aug 2024
Registered enrollment
957
Registry id
NCT04157686

Cross-registrations

EU-CTR / CTIS (EudraCT)2014-005303-24

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.